AI-guided labs are approaching full autonomy
Taking a cue from the automotive industry, the biopharma sector has been increasingly focused on autonomous capabilities as a means…
All articles by Frankie Fattorini
Frankie Fattorini
Frankie Fattorini is a healthcare and pharmaceutical reporter. His background is in genomics research, and he has also worked in medical communications. Frankie has written freelance articles on emerging technologies and various pieces on oncology and drug development.
-
-
Podcast: Autonomous labs redefine the role of biopharma researchers
Advances in robotics and artificial intelligence (AI) are leading to a rise of autonomous biopharma labs—entities that can undertake biomedical…
-
The slow march of clinical biomarkers to become surrogate endpoints
Clinicians have often pushed for certain biomarkers to move from serving a purely informative role in clinical trials to becoming…
-
The innovators working to make in vivo cell therapy a reality
As investors signal early interest in in vivo cell therapies and raise the modality’s potential for commercial success, a growing…
-
Researchers become scientific tastemakers by handing more R&D to autonomous labs
Pharmaceutical R&D is falling increasingly to artificial intelligence (AI)-guided autonomous laboratories, and the people behind them say the role of…
-
Europe’s pharma trade with the US remains critical despite tariff turmoil
US government policies of Most Favored Nation (MFN) and tariffs threaten to disrupt Europe’s pharmaceutical trade, but while European countries…
-
Podcast: Rare Disease Day: FDA guidance allowing advancement
It’s been a busy year for rare disease developers, with the US Food and Drug Administration (FDA) releasing several new…
-
Pharma eyes AI deals to stem lost revenues from patent expirations
Pharmaceutical giants are employing an array of tactics to minimise the falling revenues that come when patents expire on their…
-
Why pharma manufacturers are still investing in Europe
Undeterred by tariffs and global competition, pharma manufacturers are seeing an opportunity in Europe and continuing to invest accordingly. Europe’s…
-
JPM26: Fujifilm’s modular manufacturing answer to pharma tariffs
Fujifilm Biotechnology’s system of setting up similar manufacturing facilities across the globe —termed the ‘KojoX’ approach — has allowed the…